On Tuesday, Fulcrum Therapeutics Inc (NASDAQ: FULC) was 3.63% up from the session before settling in for the closing price of $9.65. A 52-week range for FULC has been $2.32 – $9.89.
Healthcare Sector giant saw their annual sales surged by 54.59% over the last five years. When this article was written, the company’s average yearly earnings per share was at -614.84%. With a float of $47.95 million, this company’s outstanding shares have now reached $54.09 million.
The firm has a total of 45 workers. Let’s measure their productivity.
Fulcrum Therapeutics Inc (FULC) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Fulcrum Therapeutics Inc stocks. The insider ownership of Fulcrum Therapeutics Inc is 11.36%, while institutional ownership is 91.01%. The most recent insider transaction that took place on May 08 ’25, was worth 2,520. In this transaction Principal Accounting Officer of this company sold 498 shares at a rate of $5.06, taking the stock ownership to the 14,062 shares.
Fulcrum Therapeutics Inc (FULC) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.46 earnings per share (EPS) during the time that was less than consensus figure (set at -0.4) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -614.84% per share during the next fiscal year.
Fulcrum Therapeutics Inc (NASDAQ: FULC) Trading Performance Indicators
You can see what Fulcrum Therapeutics Inc (FULC) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 24.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.21, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.19 in one year’s time.
Technical Analysis of Fulcrum Therapeutics Inc (FULC)
Analysing the last 5-days average volume posted by the [Fulcrum Therapeutics Inc, FULC], we can find that recorded value of 0.49 million was lower than the volume posted last year of 0.56 million. As of the previous 9 days, the stock’s Stochastic %D was 74.83%.
During the past 100 days, Fulcrum Therapeutics Inc’s (FULC) raw stochastic average was set at 97.22%, which indicates a significant increase from 93.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.61 in the past 14 days, which was higher than the 0.49 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.07, while its 200-day Moving Average is $5.86. Now, the first resistance to watch is $10.24. This is followed by the second major resistance level at $10.48. The third major resistance level sits at $10.84. If the price goes on to break the first support level at $9.63, it is likely to go to the next support level at $9.27. Now, if the price goes above the second support level, the third support stands at $9.03.
Fulcrum Therapeutics Inc (NASDAQ: FULC) Key Stats
There are 54,092K outstanding shares of the company, which has a market capitalization of 540.92 million. As of now, sales total 80,000 K while income totals -9,730 K. Its latest quarter income was 0 K while its last quarter net income were -17,300 K.
